SNBB active ingredient pharma cartel fined 600,000 francs in Switzerland
MLex Summary: Drugmakers Boehringer Ingelheim, Alkaloids of Australia, Alkaloids Corporation, Alchem, C2 Pharma, Linnea and Transo-Pharm agreed to fix the minimum sale price of active ingredient butylscopolamine bromide, or SNBB, to allocate...To view the full article, register now.
Already a subscriber? Click here to view full article